Home » Stocks » CNTB

Connect Biopharma Holdings Limited (CNTB)

Stock Price: $17.74 USD 0.37 (2.13%)
Updated Jun 17, 2021 12:47 PM EDT - Market open
Market Cap 990.19M
Revenue (ttm) n/a
Net Income (ttm) -119.15M
Shares Out 55.82M
EPS (ttm) -2.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 17
Last Price $17.74
Previous Close $17.37
Change ($) 0.37
Change (%) 2.13%
Day's Open 17.37
Day's Range 17.44 - 18.35
Day's Volume 20,772
52-Week Range 14.02 - 23.29

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SAN DIEGO and TAICANG, SUZHOU, China, May 26, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the “Company”), a global clinical-stage biopharmaceutical...

3 weeks ago - GlobeNewsWire

Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus

3 weeks ago - GlobeNewsWire

SAN DIEGO and TAICANG, China, April 08, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the “Company”), a global clinical-stage biopharmaceutical compa...

2 months ago - GlobeNewsWire

NEW YORK--(BUSINESS WIRE)--Deutsche Bank announced today its appointment as depositary bank for the Nasdaq-listed American Depositary Receipt program of Connect Biopharma Holdings Limited. Connect Bioph...

2 months ago - Business Wire

SAN DIEGO and TAICANG, China, March 23, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (the “Company”), a global clinical-stage biopharmaceutical company dedicated to improvi...

2 months ago - GlobeNewsWire

Last week was a busy one for the IPO market with 11 IPOs raising $3 billion, joined by 24 SPACs that brought another $8.4 billion to the table. Chinese IoT platform developer Tuya Inc (NYSE: TUYA) raise...

Other stocks mentioned: AFCG, FNCH, GANX, JWEL, NAPA, OLO, SNCY ...
2 months ago - Benzinga

SHANGHAI, March 19, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Connect Biopharma today listed on the Nasdaq with the stock code "CNTB". The issue price is US$ 17.00/ADS.

2 months ago - PRNewsWire

SAN DIEGO and TAICANG, China, March 18, 2021 -- Connect Biopharma Holdings Limited (the “Company”), a global clinical-stage...

2 months ago - GlobeNewswire

Connect Biopharma Holdings, a Chinese Phase 2 biotech developing therapies for T cell-driven inflammatory diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering.

3 months ago - NASDAQ

Connect Biopharma Holdings Limited has filed to go public with an IPO on the NASDAQ.

3 months ago - SEC

About CNTB

Connect Biopharma is a global clinical-stage biopharmaceutical company developing therapies for the treatment of inflammatory diseases with significant unmet medical need. We specialize in designing and developing product candidates that modulate the immune system, with a particular focus on T cells. Our lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis, or AD, and asthma. We have initiated a Phase 2b tr... [Read more...]

Industry
Biotechnology
IPO Date
Mar 19, 2021
CEO
Zheng Wei, Ph.D.
Employees
62
Stock Exchange
NASDAQ
Ticker Symbol
CNTB
Full Company Profile

Financial Performance

Financial numbers in millions CNY.
Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for CNTB is 30.94, which is an increase of 74.41% from the latest price.

Price Target
$30.94
(74.41% upside)